Best Addiction and Substance Abuse Grants in Virgin Islands

Virgin Islands addiction and substance use researchers can access funding through the National Institutes of Health to study SBIRT/P approaches for alcohol, tobacco, and other drug use in adults experiencing health disparities. Projects must prospectively test screening, brief intervention, and referral to treatment or prevention in collaboration with healthcare and community partners across eligible U.S. jurisdictions.

Research institutions and healthcare or community partners in the Virgin Islands and other eligible U.S. territories can apply for National Institutes of Health SBIRT/P grants to test innovative approaches to screening, brief intervention, and referral for alcohol, tobacco, and other drug use. Projects must focus on adult populations experiencing health disparities and include prospective SBIRT/P implementation research.

Researchers and research institutions studying HIV and substance use disorders, including in the Virgin Islands, can apply for NIH funding up to US $1,500,000 to conduct high-priority projects. This U.S. Dept. of Health & Human Services program supports basic, clinical, and implementation research on HIV among people who use drugs.

Academic and clinical institutions in the Virgin Islands conducting substance use and substance use disorder research can apply for this K12 career development program, which offers up to US $750,000 for mentored clinician-scientist training. Focused on addiction, drug use disorders, and medical education, the National Institutes of Health supports supervised research leading toward investigator independence.

Organizations providing research education in addiction and substance use disorders in the Virgin Islands can apply for NIH’s R25 program, with awards up to US $1,250,000. Grants from the National Institutes of Health help build a diverse substance use and addiction scientific workforce through skills-development courses and hands-on research experiences.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

Research institutions studying tobacco, alcohol, or cannabis policy impacts on addiction and substance use can apply for NIH grants up to US $275,000, including projects in the Virgin Islands. Grants from US Dept. of Health & Human Services: National Institutes of Health support U.S. policy research that advances health equity and cancer prevention through community-engaged studies.

NIH provides Virgin Islands addiction and substance use researchers with funding up to US $2,500,000 for policy studies on tobacco, alcohol, and cannabis. Projects must examine U.S. policies’ impacts on use or secondhand exposure among disparity-affected populations and authentically engage community organizations to advance health equity and cancer prevention.

The NIDA Research Education Program (R25) aims to enhance the training of a workforce skilled in biomedical, behavioral, and clinical research, particularly regarding substance use disorders. This program supports educational activities that prepare clinicians and clinical researchers. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline. This initiative does not fund non-research-related clinical training.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.

The Drug-Free Communities (DFC) Support Program aims to foster collaboration among community coalitions to combat youth substance use. Established by the Drug-Free Communities Act of 1997, it encourages partnerships among various stakeholders, including governmental and non-profit agencies. The program focuses on reducing substance use among youth and promoting protective factors within communities. This funding opportunity is available for those who have completed the initial funding cycle or experienced funding interruptions, supporting their ongoing efforts to create a healthier environment for youth.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

The Rural Communities Opioid Response Program - Overdose Response aims to enhance healthcare access in rural areas by addressing urgent needs related to substance use disorder services. This initiative focuses on reducing overdose risks through targeted interventions and support, ensuring that rural communities receive necessary assistance. Funded by the Health Resources and Services Administration, this program is crucial for mitigating the opioid crisis in underserved regions, improving health outcomes, and promoting overall community well-being.

The Rural Communities Opioid Response Program focuses on enhancing behavioral health care services for children and adolescents in rural areas. By providing essential funding, this initiative aims to tackle mental health and substance use disorders, ensuring that young individuals receive the support they need. The program, administered by the Health Resources and Services Administration, is crucial in addressing the unique challenges faced by rural communities, promoting healthier outcomes for future generations.

The Residential Treatment for Pregnant and Postpartum Women program aims to deliver essential services to women facing substance use disorders. By offering comprehensive residential treatment options, the program supports both recovery and the well-being of mothers and their children. Funded by the Substance Abuse and Mental Health Services Administration, this initiative addresses the unique challenges of pregnant and postpartum women, ensuring they receive the care necessary for a successful recovery journey.

Research institutions and similar organizations developing drugs, devices, or neurostimulation approaches for mental, substance use, or alcohol use disorders in the Virgin Islands can apply for this NIH U01 opportunity. Focused on discovery through proof-of-concept, it supports projects in pharmacology, neuroscience, biotechnology, and related medical technologies that address addiction and substance abuse treatment.

Research institutions and multidisciplinary teams in the Virgin Islands and other U.S. jurisdictions can seek funding to develop and test new drugs, neurostimulation approaches, and devices for mental disorders, substance use disorders, and alcohol use disorder. US Dept. of Health & Human Services: National Institutes of Health supports multi-project cooperative programs advancing discovery through proof-of-concept studies.

Rural health and addiction organizations in the Virgin Islands and other eligible U.S. territories can access funding to provide training and technical assistance on opioid and stimulant misuse, including polysubstance use. The Substance Abuse and Mental Health Services Administration offers up to US $650,000 to support prevention, overdose prevention, treatment, and recovery support activities through regional centers and a national office.

The National Institute on Drug Abuse (NIDA) is launching a specialized entrepreneurship program aimed at life science researchers in the field of substance use disorders (SUD). This initiative will equip researchers with essential skills to transform their innovative ideas into viable products, focusing on aspects such as market evaluation, customer discovery, and intellectual property. The course will be delivered in a hybrid format to engage US-based SUD researchers effectively, fostering collaboration and advancing the field.

Research institutions and eligible organizations in the Virgin Islands and other U.S. territories can seek NIH support for pilot or exploratory studies on time-sensitive substance use issues. US Dept. of Health & Human Services: National Institutes of Health offers up to US $275,000 for projects on emerging drug trends, policy shifts, health systems, or justice-related drug issues.

Researchers and research institutions addressing addiction and substance use disorders in the Virgin Islands can access funding through the National Institutes of Health to translate epidemiology, prevention, treatment, and recovery research into practice. Grants up to US $750,000 support scalable, evidence-based approaches to reduce substance use, misuse, and overdose, including work on recovery, care transitions, and mental health integration.

The National Institute on Drug Abuse is funding pilot and feasibility studies aimed at preparing for substance use and HIV prevention research trials. The program encourages innovative interventions for substance use disorders and HIV eradication, focusing on stakeholder collaboration and practical application. Projects may include assessment of service models, intervention development, and community engagement. This initiative is designed to fill critical research gaps and enhance partnerships, although applications are not currently being accepted.

Research institutions and eligible organizations in the Virgin Islands can apply for National Institutes of Health funding; awards up to US $3,000,000 support developing medications and interventions for substance use disorders and overdose. Projects may span preclinical to clinical research to advance prevention, diagnosis, and treatment of addiction and related health outcomes.

The Intervention Research to Improve Native American Health (IRINAH), led by the National Institute on Drug Abuse, focuses on enhancing health outcomes in Native populations. It supports research to identify causes of health issues, develop and test effective interventions, and implement strategies that promote sustainability. Emphasizing community strengths, the initiative aims to rigorously evaluate solutions to reduce health disparities, ensuring interventions can be adapted and shared across diverse communities.

The Rapid Response Opioid and Pain Management ECHO Funding Opportunity by the Association of State and Territorial Health Officials (ASTHO) aims to enhance clinician training in effective pain management strategies. This initiative focuses on non-opioid treatments, substance use screening, and risk reduction counseling, promoting compassionate care while addressing public health challenges and ensuring continuity for patients affected by prescription disruptions. The program seeks to improve overall health outcomes and reduce risks associated with opioid use.